Beta Bionics (BBNX) Gross Profit (2024 - 2026)

Beta Bionics has disclosed Gross Profit across 3 years of filings, most recently posting $18.9 million for Q2 2026.

• In Q2 2026, Gross Profit rose 51.18% year-over-year to $18.9 million; the TTM figure through Jun 2026 stood at $69.4 million (up 64.94% YoY), while the FY2025 annual figure was $55.5 million, up 54.75% from the prior year.
• Gross Profit came in at $18.9 million for Q2 2026 at Beta Bionics, up from $16.4 million in the prior quarter.
• In the past five years, Gross Profit ranged from a high of $18.9 million in Q4 2025 to a low of $7.2 million in Q1 2024.
• Average Gross Profit over 3 years is $12.7 million, with a median of $12.1 million recorded in 2024.
• Year-over-year, Gross Profit gained 24.58% in 2025 and jumped 83.22% in 2026.
• Over 3 years, Gross Profit stood at $11.7 million in 2024, then surged by 62.07% to $18.9 million in 2025, then declined by 0.22% to $18.9 million in 2026.
• Per Business Quant data, the three most recent Gross Profit figures were $18.9 million in Q2 2026, $16.4 million in Q1 2026, and $18.9 million in Q4 2025.